Chun-Jung Tsai Sells 27,718 Shares of Ainos (NASDAQ:AIMD) Stock

Ainos, Inc. (NASDAQ:AIMD) Director Chun-Jung Tsai sold 27,718 shares of the stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $1.87, for a total value of $51,832.66. Following the sale, the director owned 658,199 shares of the company’s stock, valued at approximately $1,230,832.13. This represents a 4.04% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link.

Chun-Jung Tsai also recently made the following trade(s):

• On Friday, May 22nd, Chun-Jung Tsai sold 1,082 shares of Ainos stock. The stock was sold at an average price of $1.55, for a total value of $1,677.10.

Ainos Price Performance

Shares of NASDAQ:AIMD opened at $2.74 on Friday. The company has a current ratio of 0.55, a quick ratio of 0.50 and a debt-to-equity ratio of 1.58. Ainos, Inc. has a 1 year low of $1.26 and a 1 year high of $4.50. The business has a fifty day simple moving average of $1.69 and a 200 day simple moving average of $1.83. The firm has a market cap of $23.34 million, a price-to-earnings ratio of -0.95 and a beta of 2.29.

Ainos (NASDAQ:AIMD) last announced its quarterly earnings data on Wednesday, May 13th. The company reported ($0.41) earnings per share (EPS) for the quarter. Ainos had a negative return on equity of 160.55% and a negative net margin of 11,912.10%.

Hedge Funds Weigh In On Ainos

Several institutional investors have recently bought and sold shares of AIMD. Mariner LLC bought a new position in Ainos during the fourth quarter valued at about $37,000. Two Sigma Investments LP bought a new position in Ainos during the third quarter valued at about $80,000. DRW Securities LLC raised its holdings in Ainos by 272.6% during the fourth quarter. DRW Securities LLC now owns 66,211 shares of the company’s stock valued at $109,000 after buying an additional 48,439 shares in the last quarter. Finally, Renaissance Technologies LLC raised its holdings in Ainos by 13.1% during the fourth quarter. Renaissance Technologies LLC now owns 66,300 shares of the company’s stock valued at $109,000 after buying an additional 7,700 shares in the last quarter.

Analyst Ratings Changes

Separately, Weiss Ratings raised shares of Ainos from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has an average rating of “Sell”.

About Ainos

Ainos, Inc (NASDAQ: AIMD) is a clinical?stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company’s proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations.

The lead product candidate, AI?401, is an inhaled formulation of ibuprofen in a dry powder format.